We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The PATHFNDR-2 trial enrolled adults with acromegaly who ...

We present a review of the epidemiological evidence for relations of prostate cancer risk to circulating total and bioavailable androgens, to alterations in the metabolism of insulin-like growth ...

Findings showed 56% of patients who received paltusotine achieved an IGF-1 level equal to or less than 1 times the ULN compared with 5% of those who received placebo. Treatment with paltusotine ...

The U.S. Food and Drug Administration approved Crinetics Pharmaceuticals' drug to treat a rare hormonal disorder on Thursday, making it the first once-daily oral pill available for patients in the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio More than 80% of adults with acromegaly ...